Quotient Therapeutics

Quotient Therapeutics is a biotechnology company focused on developing transformative medicines through the application of somatic genomics. The company employs a unique platform that utilizes a four-step process—phenotyping, isolation, genotyping, and computation—to identify and target naturally occurring human disease targets. This approach allows Quotient Therapeutics to direct drug development efforts more effectively, enhancing the potential for creating innovative therapeutics. By leveraging insights from natural target selection, the company aims to address unmet medical needs and advance the field of drug discovery.

Jacob Rubens

CEO

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.